[{"address1": "2 Holzman Street", "address2": "Science Park PO Box 4081", "city": "Rehovot", "zip": "7670402", "country": "Israel", "phone": "972 8 940 6472", "fax": "972 8 940 6473", "website": "https://www.kamada.com", "industry": "Drug Manufacturers - Specialty & Generic", "industryKey": "drug-manufacturers-specialty-generic", "industryDisp": "Drug Manufacturers - Specialty & Generic", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Kamada Ltd. manufactures and sells plasma-derived protein therapeutics. Its products include KAMRAB/KEDRAB indicated as prophylaxis of rabies; CYTOGAM for prophylaxis of Cytomegalovirus disease in kidney, lung, liver, pancreas, heart, and heart/lung transplants; VARIZIG for post exposure prophylaxis of varicella; WINRHO SDF for immune thrombocytopenic purpura and suppression of rhesus isoimmunization; HEPAGAM B for prevention of hepatitis B recurrence liver transplants and post-exposure prophylaxis; GLASSIA for intravenous AATD; KAMRHO (D) IM for prophylaxis of hemolytic disease of newborns; and Echis coloratus and Vipera palaestinae Antiserum to treat snake bite. The company also distributes biopharmaceutical products in Israel, including BRAMITOB to manage chronic pulmonary infection; FOSTER to treat asthma; TRIMBOW for chronic obstructive pulmonary disease; PROVOCHOLINE for the diagnosis of bronchial airway hyperactivity; AEROBIKA, an OPEP device; RUPAFIN and RUPAFIN ORAL SOLUTION for allergic rhinitis and Urticaria; SINTREDIUS for rheumatoid arthritis, systemic lupus erythematosus, and mild-moderate juvenile dermatomyositis; IVIG for various immunodeficiency-related conditions; VARITECT for chicken pox and zoster herpes; ZUTECTRA and HEPATECT CP for prevention of hepatitis B; MEGALOTECT CP for CMV virus; RUCONEST for angioedema attack; HEPARIN SODIUM INJECTION for thrombo-embolic disorders and prophylaxis of deep vein thrombosis and thromboembolic events; ALBUMIN and ALBUMIN for blood plasma; Factor VIII for hemophilia type A; and Factor IX for hemophilia type B. In addition, it distributes COAGADEX to treat hereditary factor X deficiency; IXIARO for Japanese encephalitis; VIVOTIF for salmonella typhi; PROCYSBI for nephropathic cystinosis; LAMZEDE for alpha-mannosidosis; RYPLAZIM for hypoplasminogenemia; ELIGARD for prostate cancer; and BEVACIZUMAB KAMADA for various cancers. The company was incorporated in 1990 and is headquartered in Rehovot, Israel.", "fullTimeEmployees": 420, "companyOfficers": [{"maxAge": 1, "name": "Mr. Amir  London", "age": 56, "title": "Chief Executive Officer", "yearBorn": 1969, "fiscalYear": 2024, "totalPay": 674000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Chaime  Orlev", "age": 55, "title": "Chief Financial Officer", "yearBorn": 1970, "fiscalYear": 2024, "totalPay": 478000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Eran  Nir", "age": 52, "title": "Chief Operating Officer", "yearBorn": 1973, "fiscalYear": 2024, "totalPay": 417000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jon R. Knight", "age": 59, "title": "Vice President of US Commercial Operations", "yearBorn": 1966, "fiscalYear": 2024, "totalPay": 302000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Boris  Gorelik", "age": 43, "title": "Vice President of Business Development & Strategic Programs", "yearBorn": 1982, "fiscalYear": 2024, "totalPay": 392000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. David  Tsur", "age": 75, "title": "Co-Founder & Independent Deputy Chairman of the Board", "yearBorn": 1950, "fiscalYear": 2024, "totalPay": 252000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Nir  Livneh B.A., L.L.B.", "age": 45, "title": "VP, General Counsel & Corporate Secretary", "yearBorn": 1980, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Hanni  Neheman", "age": 55, "title": "Vice President of Marketing & Sales", "yearBorn": 1970, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Liron  Reshef", "age": 53, "title": "Vice President of Human Resources", "yearBorn": 1972, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Shavit  Beladev", "title": "Vice President of Kamada Plasma", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 8.22, "open": 8.24, "dayLow": 8.12, "dayHigh": 8.3411, "regularMarketPreviousClose": 8.22, "regularMarketOpen": 8.24, "regularMarketDayLow": 8.12, "regularMarketDayHigh": 8.3411, "exDividendDate": 1742169600, "payoutRatio": 0.0, "beta": 0.21, "trailingPE": 23.342857, "forwardPE": 17.020834, "volume": 70712, "regularMarketVolume": 70712, "averageVolume": 79811, "averageVolume10days": 90530, "averageDailyVolume10Day": 90530, "bid": 8.09, "ask": 8.19, "bidSize": 1, "askSize": 1, "marketCap": 471905984, "fiftyTwoWeekLow": 5.54, "fiftyTwoWeekHigh": 9.15, "allTimeHigh": 17.95, "allTimeLow": 3.02, "priceToSalesTrailing12Months": 2.6998916, "fiftyDayAverage": 7.1216, "twoHundredDayAverage": 7.0306, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 420232096, "profitMargins": 0.116969995, "floatShares": 9549865, "sharesOutstanding": 57681590, "sharesShort": 71840, "sharesShortPriorMonth": 45256, "sharesShortPreviousMonthDate": 1764288000, "dateShortInterest": 1767139200, "sharesPercentSharesOut": 0.0011999999, "heldPercentInsiders": 0.07195, "heldPercentInstitutions": 0.49806, "shortRatio": 0.76, "shortPercentOfFloat": 0.0023, "impliedSharesOutstanding": 57760827, "bookValue": 4.507, "priceToBook": 1.8127358, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "earningsQuarterlyGrowth": 0.371, "netIncomeToCommon": 20444000, "trailingEps": 0.35, "forwardEps": 0.48, "enterpriseToRevenue": 2.404, "enterpriseToEbitda": 10.13, "52WeekChange": 0.16101694, "SandP52WeekChange": 0.14799047, "lastDividendValue": 0.2, "lastDividendDate": 1742169600, "quoteType": "EQUITY", "currentPrice": 8.17, "targetHighPrice": 15.0, "targetLowPrice": 11.0, "targetMeanPrice": 13.0, "targetMedianPrice": 13.0, "recommendationMean": 1.0, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 4, "totalCash": 71997000, "totalCashPerShare": 1.224, "ebitda": 41485000, "totalDebt": 11470000, "quickRatio": 2.243, "currentRatio": 4.029, "totalRevenue": 174787008, "debtToEquity": 4.325, "revenuePerShare": 2.99, "returnOnAssets": 0.04764, "returnOnEquity": 0.07856, "grossProfits": 76471000, "freeCashflow": 7821750, "operatingCashflow": 28322000, "earningsGrowth": 0.286, "revenueGrowth": 0.126, "grossMargins": 0.43750998, "ebitdaMargins": 0.23735, "operatingMargins": 0.16625999, "financialCurrency": "USD", "symbol": "KMDA", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "postMarketTime": 1768597477, "regularMarketTime": 1768597202, "exchange": "NMS", "messageBoardId": "finmb_9002466", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "priceEpsCurrentYear": 22.231293, "fiftyDayAverageChange": 1.0483999, "fiftyDayAverageChangePercent": 0.1472141, "twoHundredDayAverageChange": 1.1394, "twoHundredDayAverageChangePercent": 0.16206299, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.0 - Strong Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1370007000000, "postMarketChangePercent": 0.0, "marketState": "CLOSED", "regularMarketChangePercent": -0.608275, "regularMarketPrice": 8.17, "postMarketPrice": 8.17, "postMarketChange": 0.0, "regularMarketChange": -0.0500002, "regularMarketDayRange": "8.12 - 8.3411", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 79811, "fiftyTwoWeekLowChange": 2.63, "fiftyTwoWeekLowChangePercent": 0.47472927, "fiftyTwoWeekRange": "5.54 - 9.15", "fiftyTwoWeekHighChange": -0.97999954, "fiftyTwoWeekHighChangePercent": -0.10710378, "fiftyTwoWeekChangePercent": 16.101694, "dividendDate": 1743984000, "earningsTimestamp": 1762781400, "earningsTimestampStart": 1772631000, "earningsTimestampEnd": 1772631000, "earningsCallTimestampStart": 1762781400, "earningsCallTimestampEnd": 1762781400, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": 0.35, "epsForward": 0.48, "epsCurrentYear": 0.3675, "shortName": "Kamada Ltd.", "longName": "Kamada Ltd.", "displayName": "Kamada", "trailingPegRatio": 0.7446, "__fetch_time": "2026-01-17"}]